Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0494
+0.0023 (4.78%)
Feb 11, 2026, 3:34 PM EST
Bioxytran Employees
Bioxytran had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
5.56M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | 2 | 0 | - |
| Dec 31, 2019 | 2 | 0 | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| LakeShore Biopharma | 573 |
| Orgenesis | 146 |
| Clearside Biomedical | 32 |
| Brainstorm Cell Therapeutics | 23 |
| AXIM Biotechnologies | 7 |
| Synlogic | 1 |
Bioxytran News
- 1 day ago - Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran - GlobeNewsWire
- 10 days ago - Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics - GlobeNewsWire
- 3 months ago - Bioxytran Announces Initiation of Coverage of its Stock by Independent Research - GlobeNewsWire
- 3 months ago - Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug - GlobeNewsWire
- 6 months ago - Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation - GlobeNewsWire
- 6 months ago - Bioxytran's Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment - GlobeNewsWire
- 8 months ago - Bioxytran Secures a Source of GMP Quality Camel Hemoglobin - GlobeNewsWire
- 9 months ago - Bioxytran's Groundbreaking Stroke & Alzheimer's Tech Gains Validation That Measures Oxygenation Uptake During Strokes - GlobeNewsWire